S
Sureshbabu
About Sureshbabu
Data last updated:
Sureshbabu is a Director at Sree Parthas Multi Specialty Hospital Private Limited (since 2020) and Partner at Spaderan Pharmaceuticals India Llp (since 2026). The companies operate in Healthcare. The largest current company by reported revenue is Sree Parthas Multi Specialty Hospital Private Limited at ₹16.66 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sree Parthas Multi Specialty Hospital Private Limited U85300TN2019PTC129896 | Director | 18 May 2020 | 2019 | ₹16.66 Cr (FY 2025) | Active |
| Spaderan Pharmaceuticals India Llp ADA-2586 | Partner | 13 Aug 2026 | 2026 | Active |
Board colleagues of Sureshbabu
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sureshbabu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sureshbabu
Sureshbabu currently holds 2 directorships: Sree Parthas Multi Specialty Hospital Private Limited (Director, since 18 May 2020, revenue ₹16.66 Cr (FY 2025)); Spaderan Pharmaceuticals India Llp (Partner, since 13 Aug 2026).
Sureshbabu was first appointed on 18 May 2020 as Director at Sree Parthas Multi Specialty Hospital Private Limited. The most recent appointment on record is 13 Aug 2026 at Spaderan Pharmaceuticals India Llp.
The current boards of Sureshbabu's companies include Ariyalur Harigopal Balaji (Sree Parthas Multi Specialty Hospital Private Limited), Jeya Yuvaraj Ruban Moses (Sree Parthas Multi Specialty Hospital Private Limited), Mahadevan (Sree Parthas Multi Specialty Hospital Private Limited), Praveenkumar Thota (Sree Parthas Multi Specialty Hospital Private Limited), Ramesh (Sree Parthas Multi Specialty Hospital Private Limited), Sangeetha (Sree Parthas Multi Specialty Hospital Private Limited), among others.